Another company I own with stem cell indications (autologous) has had a massive rally in the last two months, in part due to AFR recognition of its future. Sentiment still rules over decent valuation analysis every time. Hence grateful for the CYP mention as an investor. WE know the valuation arguments.
Another company I own with stem cell indications (autologous)...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.3¢ |
Change
-0.003(1.52%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.3¢ | $46.59K | 282.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1313831 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 37527 | 4 |
View Market Depth
| Last trade - 14.20pm 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |